←Back to Expert Scholars
Translational Medicine / 转化医学Marginal Zone and Mantle Cell Lymphoma
Martin Dreyling
MD
🏢LMU University Hospital Munich🌐Germany
Professor of Medicine, Head of Lymphoma Program
80
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Martin Dreyling chairs the European Mantle Cell Lymphoma Network and has led pivotal trials in mantle cell and marginal zone lymphomas including BTK inhibitor studies. He directs the lymphoma program at LMU Munich.
Share:
🧪Research Fields 研究领域
mantle cell lymphoma
marginal zone lymphoma
BTK inhibitors
European Mantle Cell Lymphoma Network
indolent lymphoma
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Martin Dreyling 的研究动态
Follow Martin Dreyling's research updates
留下邮箱，当我们发布与 Martin Dreyling（LMU University Hospital Munich）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment